Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Core EBITDA Growth

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023
   Core EBITDA Growth(%) 96.50-

What is the latest Core EBITDA Growth ratio of GENPHARMASEC ?

The latest Core EBITDA Growth ratio of GENPHARMASEC is 96.50 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202496.50
Mar2023-

How is Core EBITDA Growth of GENPHARMASEC Trending?

Years Core EBITDA Growth % Change
Mar2024 96.5
0
Mar2023 0 -

Other Financial Ratios of GENPHARMASEC


Compare Core EBITDA Growth ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹111.8 Cr NA -8.2% -14.1% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹9,585.1 Cr -1% -2.5% 36.5% Stock Analytics
KIRI INDUSTRIES ₹3,067.4 Cr -0.6% -6.5% 55.3% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹2,047.0 Cr -1.3% -3% -2.3% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,135.4 Cr 5.6% 9.6% 44.2% Stock Analytics
BODAL CHEMICALS ₹949.4 Cr -2% 1% -5.4% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC NA

-8.2%

-14.1%

SENSEX

-1.1%

-0%

3.2%


You may also like the below Video Courses